Healthcare Services Group, Inc. (HCSG)
USD 9.37
(-1.58%)
USD 9.37
(-1.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 62.35 Million USD | 16.57% |
| 2022 | 53.49 Million USD | 72.3% |
| 2021 | 31.04 Million USD | -65.87% |
| 2020 | 90.96 Million USD | 60.36% |
| 2019 | 56.72 Million USD | -43.41% |
| 2018 | 100.23 Million USD | -21.0% |
| 2017 | 126.88 Million USD | 7.76% |
| 2016 | 117.75 Million USD | 32.23% |
| 2015 | 89.05 Million USD | 196.05% |
| 2014 | 30.08 Million USD | -52.09% |
| 2013 | 62.78 Million USD | -6.77% |
| 2012 | 67.34 Million USD | 18.56% |
| 2011 | 56.8 Million USD | 10.3% |
| 2010 | 51.49 Million USD | 15.18% |
| 2009 | 44.71 Million USD | 6.64% |
| 2008 | 41.92 Million USD | -4.87% |
| 2007 | 44.07 Million USD | 23.05% |
| 2006 | 35.81 Million USD | 29.77% |
| 2005 | 27.6 Million USD | 23.63% |
| 2004 | 22.32 Million USD | 38.98% |
| 2003 | 16.06 Million USD | 19.05% |
| 2002 | 13.49 Million USD | 31.16% |
| 2001 | 10.28 Million USD | 26.23% |
| 2000 | 8.14 Million USD | 3.16% |
| 1999 | 7.9 Million USD | -39.69% |
| 1998 | 13.1 Million USD | 40.86% |
| 1997 | 9.3 Million USD | -9.71% |
| 1996 | 10.3 Million USD | 8.42% |
| 1995 | 9.5 Million USD | -8.65% |
| 1994 | 10.4 Million USD | 16.85% |
| 1993 | 8.9 Million USD | 28.99% |
| 1992 | 6.9 Million USD | 3350.0% |
| 1991 | 200 Thousand USD | -97.56% |
| 1990 | 8.2 Million USD | 32.26% |
| 1989 | 6.2 Million USD | 113.79% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 18.95 Million USD | 892.56% |
| 2024 Q1 | 18.31 Million USD | -60.04% |
| 2024 Q2 | -2.39 Million USD | -113.06% |
| 2023 Q3 | -5.21 Million USD | -153.34% |
| 2023 FY | 62.35 Million USD | 16.57% |
| 2023 Q4 | 45.82 Million USD | 978.98% |
| 2023 Q1 | 12.48 Million USD | 8.02% |
| 2023 Q2 | 9.77 Million USD | -21.71% |
| 2022 Q3 | -1.2 Million USD | -107.44% |
| 2022 Q2 | 16.2 Million USD | -9.02% |
| 2022 Q1 | 17.81 Million USD | 1760.11% |
| 2022 FY | 53.49 Million USD | 72.3% |
| 2022 Q4 | 11.55 Million USD | 1058.37% |
| 2021 Q4 | -1.07 Million USD | -108.95% |
| 2021 Q1 | 31.14 Million USD | 7.33% |
| 2021 FY | 31.04 Million USD | -65.87% |
| 2021 Q2 | 11.7 Million USD | -62.4% |
| 2021 Q3 | 11.98 Million USD | 2.38% |
| 2020 Q3 | 33.16 Million USD | 43.91% |
| 2020 Q1 | 31.97 Million USD | 36.63% |
| 2020 FY | 90.96 Million USD | 60.36% |
| 2020 Q4 | 29.01 Million USD | -12.51% |
| 2020 Q2 | 23.04 Million USD | -27.93% |
| 2019 Q1 | 7.74 Million USD | -80.22% |
| 2019 FY | 56.72 Million USD | -43.41% |
| 2019 Q4 | 23.4 Million USD | -1.34% |
| 2019 Q3 | 23.72 Million USD | 3.11% |
| 2019 Q2 | 23 Million USD | 197.06% |
| 2018 Q4 | 39.15 Million USD | 26.5% |
| 2018 Q2 | 31.99 Million USD | 1810.1% |
| 2018 Q1 | -1.87 Million USD | -105.65% |
| 2018 FY | 100.23 Million USD | -21.0% |
| 2018 Q3 | 30.95 Million USD | -3.25% |
| 2017 Q3 | 31.49 Million USD | -0.23% |
| 2017 Q4 | 33.12 Million USD | 5.19% |
| 2017 Q2 | 31.56 Million USD | 2.78% |
| 2017 FY | 126.88 Million USD | 7.76% |
| 2017 Q1 | 30.71 Million USD | 0.88% |
| 2016 FY | 117.75 Million USD | 32.23% |
| 2016 Q3 | 29.21 Million USD | 1.85% |
| 2016 Q4 | 30.44 Million USD | 4.21% |
| 2016 Q1 | 29.41 Million USD | 182.45% |
| 2016 Q2 | 28.68 Million USD | -2.5% |
| 2015 Q2 | 26.01 Million USD | 5.98% |
| 2015 Q3 | 28.07 Million USD | 7.92% |
| 2015 Q4 | 10.41 Million USD | -62.9% |
| 2015 FY | 89.05 Million USD | 196.05% |
| 2015 Q1 | 24.54 Million USD | 16.2% |
| 2014 Q3 | -35.03 Million USD | -264.94% |
| 2014 Q2 | 21.24 Million USD | -6.63% |
| 2014 Q1 | 22.74 Million USD | 336.04% |
| 2014 Q4 | 21.12 Million USD | 160.3% |
| 2014 FY | 30.08 Million USD | -52.09% |
| 2013 Q2 | 19.63 Million USD | 9.57% |
| 2013 Q1 | 17.92 Million USD | -6.77% |
| 2013 Q3 | 20 Million USD | 1.88% |
| 2013 Q4 | 5.21 Million USD | -73.93% |
| 2013 FY | 62.78 Million USD | -6.77% |
| 2012 FY | 67.34 Million USD | 18.56% |
| 2012 Q3 | 17.61 Million USD | -4.17% |
| 2012 Q2 | 18.37 Million USD | 51.52% |
| 2012 Q1 | 12.12 Million USD | -15.64% |
| 2012 Q4 | 19.22 Million USD | 9.16% |
| 2011 FY | 56.8 Million USD | 10.3% |
| 2011 Q4 | 14.37 Million USD | -13.09% |
| 2011 Q2 | 14.25 Million USD | 22.62% |
| 2011 Q1 | 11.62 Million USD | -13.01% |
| 2011 Q3 | 16.54 Million USD | 16.07% |
| 2010 Q2 | 14.56 Million USD | 28.58% |
| 2010 Q1 | 11.32 Million USD | 14.94% |
| 2010 Q4 | 13.36 Million USD | 9.17% |
| 2010 FY | 51.49 Million USD | 15.18% |
| 2010 Q3 | 12.24 Million USD | -15.94% |
| 2009 Q3 | 11.66 Million USD | 1.0% |
| 2009 Q2 | 11.55 Million USD | -0.78% |
| 2009 FY | 44.71 Million USD | 6.64% |
| 2009 Q1 | 11.64 Million USD | 3.51% |
| 2009 Q4 | 9.85 Million USD | -15.52% |
| 2008 Q4 | 11.24 Million USD | 23.11% |
| 2008 Q2 | 10.72 Million USD | -0.98% |
| 2008 FY | 41.92 Million USD | -4.87% |
| 2008 Q1 | 10.82 Million USD | -4.12% |
| 2008 Q3 | 9.13 Million USD | -14.79% |
| 2007 Q1 | 10.85 Million USD | 8.78% |
| 2007 Q2 | 11.18 Million USD | 3.07% |
| 2007 FY | 44.07 Million USD | 23.05% |
| 2007 Q4 | 11.29 Million USD | 5.13% |
| 2007 Q3 | 10.74 Million USD | -4.0% |
| 2006 Q2 | 8.87 Million USD | 13.12% |
| 2006 Q1 | 7.84 Million USD | 0.89% |
| 2006 FY | 35.81 Million USD | 29.77% |
| 2006 Q4 | 9.97 Million USD | 9.4% |
| 2006 Q3 | 9.12 Million USD | 2.78% |
| 2005 FY | 27.6 Million USD | 23.63% |
| 2005 Q4 | 7.77 Million USD | 14.76% |
| 2005 Q3 | 6.77 Million USD | 3.39% |
| 2005 Q2 | 6.55 Million USD | -82.04% |
| 2005 Q1 | 36.49 Million USD | 501.66% |
| 2004 Q1 | 5.2 Million USD | 36.78% |
| 2004 Q2 | 5.38 Million USD | 3.42% |
| 2004 Q3 | 5.71 Million USD | 6.03% |
| 2004 Q4 | 6.06 Million USD | 6.17% |
| 2004 FY | 22.32 Million USD | 38.98% |
| 2003 Q2 | 4.09 Million USD | 1.23% |
| 2003 FY | 16.06 Million USD | 19.05% |
| 2003 Q4 | 3.8 Million USD | -7.49% |
| 2003 Q3 | 4.11 Million USD | 0.59% |
| 2003 Q1 | 4.04 Million USD | 20.58% |
| 2002 Q3 | 3.53 Million USD | 3.06% |
| 2002 Q2 | 3.43 Million USD | 8.28% |
| 2002 Q4 | 3.35 Million USD | -5.2% |
| 2002 Q1 | 3.16 Million USD | 19.47% |
| 2002 FY | 13.49 Million USD | 31.16% |
| 2001 Q2 | 2.53 Million USD | 7.41% |
| 2001 Q3 | 2.73 Million USD | 7.62% |
| 2001 Q4 | 2.65 Million USD | -2.89% |
| 2001 FY | 10.28 Million USD | 26.23% |
| 2001 Q1 | 2.36 Million USD | 311.7% |
| 2000 Q4 | 574.1 Thousand USD | -78.72% |
| 2000 FY | 8.14 Million USD | 3.16% |
| 2000 Q3 | 2.69 Million USD | 2.54% |
| 2000 Q2 | 2.63 Million USD | 17.02% |
| 2000 Q1 | 2.24 Million USD | 170.25% |
| 1999 Q4 | -3.2 Million USD | -186.49% |
| 1999 Q3 | 3.7 Million USD | 5.71% |
| 1999 FY | 7.9 Million USD | -39.69% |
| 1999 Q1 | 3.9 Million USD | 5.41% |
| 1999 Q2 | 3.5 Million USD | -10.26% |
| 1998 Q3 | 2.8 Million USD | -12.5% |
| 1998 Q2 | 3.2 Million USD | -3.03% |
| 1998 Q1 | 3.3 Million USD | 200.0% |
| 1998 FY | 13.1 Million USD | 40.86% |
| 1998 Q4 | 3.7 Million USD | 32.14% |
| 1997 Q1 | 2.6 Million USD | 30.0% |
| 1997 Q4 | 1.1 Million USD | -60.71% |
| 1997 Q3 | 2.8 Million USD | 3.7% |
| 1997 Q2 | 2.7 Million USD | 3.85% |
| 1997 FY | 9.3 Million USD | -9.71% |
| 1996 Q3 | 2.6 Million USD | -10.34% |
| 1996 Q1 | 2.8 Million USD | 33.33% |
| 1996 FY | 10.3 Million USD | 8.42% |
| 1996 Q4 | 2 Million USD | -23.08% |
| 1996 Q2 | 2.9 Million USD | 3.57% |
| 1995 FY | 9.5 Million USD | -8.65% |
| 1995 Q3 | 2.3 Million USD | -4.17% |
| 1995 Q2 | 2.4 Million USD | -11.11% |
| 1995 Q1 | 2.7 Million USD | 22.73% |
| 1995 Q4 | 2.1 Million USD | -8.7% |
| 1994 Q1 | 2.5 Million USD | -3.85% |
| 1994 Q3 | 3 Million USD | 15.38% |
| 1994 Q4 | 2.2 Million USD | -26.67% |
| 1994 FY | 10.4 Million USD | 16.85% |
| 1994 Q2 | 2.6 Million USD | 4.0% |
| 1993 FY | 8.9 Million USD | 28.99% |
| 1993 Q4 | 2.6 Million USD | -16.13% |
| 1993 Q2 | 2.3 Million USD | 27.78% |
| 1993 Q1 | 1.8 Million USD | 50.0% |
| 1993 Q3 | 3.1 Million USD | 34.78% |
| 1992 Q3 | 2.1 Million USD | 10.53% |
| 1992 Q1 | 1.6 Million USD | 121.05% |
| 1992 FY | 6.9 Million USD | 3350.0% |
| 1992 Q2 | 1.9 Million USD | 18.75% |
| 1992 Q4 | 1.2 Million USD | -42.86% |
| 1991 Q4 | -7.6 Million USD | -371.43% |
| 1991 Q3 | 2.8 Million USD | 3.7% |
| 1991 FY | 200 Thousand USD | -97.56% |
| 1991 Q2 | 2.7 Million USD | 12.5% |
| 1991 Q1 | 2.4 Million USD | 4.35% |
| 1990 Q3 | 2 Million USD | -4.76% |
| 1990 Q2 | 2.1 Million USD | 10.53% |
| 1990 FY | 8.2 Million USD | 32.26% |
| 1990 Q1 | 1.9 Million USD | 105.49% |
| 1990 Q4 | 2.3 Million USD | 15.0% |
| 1989 FY | 6.2 Million USD | 113.79% |
| 1989 Q4 | -34.6 Million USD | -343.66% |
| 1989 Q2 | 13.6 Million USD | 4.62% |
| 1989 Q1 | 13 Million USD | 158.3% |
| 1989 Q3 | 14.2 Million USD | 4.41% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 87.691% |
| Addus HomeCare Corporation | 90.95 Million USD | 31.442% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -557.577% |
| Amedisys, Inc. | 156.39 Million USD | 60.128% |
| American Oncology Network, Inc. | -49.15 Million USD | 226.863% |
| Astrana Health, Inc. | 84.61 Million USD | 26.302% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -672.522% |
| IMAC Holdings, Inc. | -6.37 Million USD | 1078.087% |
| biote Corp. | 28.65 Million USD | -117.601% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 606.809% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 44.675% |
| COMPASS Pathways plc | -136.91 Million USD | 145.544% |
| DocGo Inc. | 15.05 Million USD | -314.202% |
| The Ensign Group, Inc. | 255.36 Million USD | 75.581% |
| InnovAge Holding Corp. | -23.18 Million USD | 369.016% |
| Assure Holdings Corp. | -20.08 Million USD | 410.517% |
| The Joint Corp. | -2.07 Million USD | 3107.978% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 132.97% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 497.09% |
| ModivCare Inc. | -139.94 Million USD | 144.559% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -147520.851% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 829.064% |
| Option Care Health, Inc. | 314.59 Million USD | 80.178% |
| P3 Health Partners Inc. | -167.86 Million USD | 137.149% |
| P3 Health Partners Inc. | -167.86 Million USD | 137.149% |
| The Pennant Group, Inc. | 25.16 Million USD | -147.757% |
| Surgery Partners, Inc. | 328 Million USD | 80.988% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 2259.51% |
| Talkspace, Inc. | -23.2 Million USD | 368.68% |
| Talkspace, Inc. | -23.2 Million USD | 368.68% |
| The Oncology Institute, Inc. | -77.01 Million USD | 180.965% |
| The Oncology Institute, Inc. | -77.01 Million USD | 180.965% |